Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US
Fierce Pharma
MARCH 14, 2023
Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US kdunleavy Tue, 03/14/2023 - 10:56
Fierce Pharma
MARCH 14, 2023
Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US kdunleavy Tue, 03/14/2023 - 10:56
MedCity News
DECEMBER 5, 2023
Replimune’s lead therapeutic candidate did not meet the two main goals of a study intended to support an FDA submission in cutaneous squamous cell carcinoma. But Replimune’s therapy, an oncolytic virus, has better data in melanoma, and the company plans a 2024 FDA submission in this skin cancer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
MAY 22, 2023
With Dupixent leading the way, Sanofi’s taking on the 'big players' in respiratory diseases: exec kdunleavy Mon, 05/22/2023 - 07:33
Fierce Pharma
OCTOBER 2, 2023
With Novo Nordisk, Eli Lilly and AstraZeneca leading the way, Big Pharma's sales will grow 4% annually through 2030: analysts kdunleavy Mon, 10/02/2023 - 15:19
Advertisement
Sponsors can face a number of challenges when trying to obtain these critical supplies for their studies, including addressing product lead times, availability, expiry limitations, safety and cost, among others.
Fierce Pharma
NOVEMBER 29, 2022
LTS Lohmann leads investment in needle-free delivery specialist. Tue, 11/29/2022 - 10:21.
pharmaphorum
NOVEMBER 20, 2023
Generics group says VPAG may lead to shortages Phil.Taylor Mon, 20/11/2023 - 18:08 Bookmark this
Advertiser: ZoomInfo
When the dust settles, we have a responsibility to turn our shock and grief into fierce determination and lead the charge of responsible, strategic, and sustainable future growth. However, there’s no team better suited to lead that charge than the marketing department. Getting consensus on how to define “qualified leads”.
Advertiser: ZoomInfo
In this eBook, we’ll cover: How you should respond to inbound leads Tactics for engaging outbound leads (cold calls, email automation, and gifts) The key to keeping a prospective account alive for the long haul Buckle up! The art is what you bring to the table—your flair for conversation, your work ethic, your dedication.
Advertiser: ZoomInfo
Those implementing a B2B sales and marketing intelligence solution reported that they have realized 35% more leads in their pipeline and 45% higher-quality leads leading to higher revenue and growth. However, organizations are fighting back - and winning.
Advertiser: ZoomInfo
This is your chance to create unprecedented brand awareness, bring in the best leads sales has ever seen, and play an instrumental role in generating new and existing business revenue. Define and agree on “qualified leads”. In this eBook, you’ll discover what it takes to develop and drive a successful marketing-led growth strategy.
Advertiser: ZoomInfo
Leveraging leading industry research from industry analysts, this eBook explores how your sales team can gain back valuable time with the following: Conquering the most difficult pain points in your CRM. Leading integrations that fit directly into your CRM and workflow. The result? Combatting low adoption rates and data quality.
Advertiser: ZoomInfo
Read on to learn more about how intent data can save salespeople time -- while capturing more qualified leads in the process! Not only that, but using it will save immense time during your workflow; a win-win on all fronts.
Advertiser: ZoomInfo
How AI-powered analytics are leading to more intriguing and satisfying customer interactions. The growing demand among buyers for open marketing platforms that can support “BYOD” (bring your own data).
Advertiser: ZoomInfo
Nurturing leads through your sales funnel is a daunting task for many business development teams, especially at the scale required to achieve lofty growth goals. But personalized prospecting is possible at scale with the right resources in place. At ZoomInfo, we’ve found that a rock-solid go-to-market playbook is key.
Let's personalize your content